IO Biotech Inc IOBT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:32 AM EDT
1.40UNCH (UNCH)
Volume
25,061
52 week range
0.82 - 2.28
Loading...
  • Open1.42
  • Day High1.48
  • Day Low1.39
  • Prev Close1.40
  • 52 Week High2.28
  • 52 Week High Date05/25/23
  • 52 Week Low0.82
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap92.233M
  • Shares Out65.88M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.55
  • YTD % Change-25.53

KEY STATS

  • Open1.42
  • Day High1.48
  • Day Low1.39
  • Prev Close1.40
  • 52 Week High2.28
  • 52 Week High Date05/25/23
  • 52 Week Low0.82
  • 52 Week Low Date10/30/23
  • Market Cap92.233M
  • Shares Out65.88M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.55
  • YTD % Change-25.53

RATIOS/PROFITABILITY

  • EPS (TTM)-1.86
  • P/E (TTM)-0.75
  • Fwd P/E (NTM)-0.97
  • EBITDA (TTM)-93.486M
  • ROE (TTM)-73.84%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/11/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On IO Biotech Inc

 

Profile

MORE
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO...
Peter Hirth Ph.D.
Chairman of the Board
Mai-Britt Zocca Ph.D.
President, Chief Executive Officer, Founder, Director
Amy Sullivan
Chief Financial Officer
Brian Burkavage
Chief Accounting Officer
Devin Smith
General Counsel
Address
Ole Maaloes Veh 3
Copenhagen
2200
Denmark

Top Peers

SYMBOLLASTCHG%CHG
ELTX
Elicio Therapeutics Inc
10.25+0.87+9.28%
ANIX
Anixa Biosciences Inc
2.87-0.04-1.37%
PASG
Passage Bio Inc
1.39+0.05+3.72%
MIST
Milestone Pharmaceuticals Inc
1.75UNCHUNCH
ALVR
Allovir Inc
0.7613+0.0099+1.3175%